z-logo
Premium
D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia
Author(s) -
Safic Stanic Hana,
Dogic Vesna,
Herceg Ivona,
Jagnjic Sandra,
BingulacPopovic Jasna,
Babic Ivana,
Corusic Ante,
Jukic Irena
Publication year - 2021
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12726
Subject(s) - genotyping , allele , polymerase chain reaction , genotype , population , biology , rh blood group system , blood type (non human) , microbiology and biotechnology , gene , genetics , antibody , medicine , abo blood group system , environmental health
Objectives The aim of this study was to determine RHESUS D GENE ( RHD) allelic variants among Croatian D‐negative blood donors and compare our results with respective data from other European countries. Background Altered or reduced D antigen expression can result in D variants, which can be mistyped and can lead to the alloimmunisation of the blood recipient. RHD genotyping can distinguish D variants: weak D, partial D and DEL, thus preventing alloimmunisation. Material/methods A total of 6523 samples obtained from D‐negative Croatian donors were screened for the presence of RHD using the real‐time polymerase chain reaction (PCR) method. PCR‐SSP was performed for D variant genotyping by using commercial genotyping kits (Inno‐Train, Kronberg, Germany). Genomic DNA sequencing for all 10 exons of the RHD was performed when the genotyping kits failed to assign a D variant. Results RHD molecular screening revealed 23 (0.35%) RHD ‐PCR positive samples, all C/E positive, in decreasing frequency: 11 hybrid RHD‐CE (2‐9) D‐CE variants, 4 weak partial D type 11 and 2 weak D type 2. Six samples remained unresolved and were sequenced. For 12 of 23 samples (excluding large hybrids), an adsorption/elution of anti‐D serum was performed, confirming that all 12 were RhD+. The calculated frequency of clinically significant D alleles in RhD‐negative blood donors was 1:543 (0.18%) or 1:53 (1.89%) in C/E blood donors. Conclusion Data on the significant frequency of D variants among serologically D‐negative blood donors in the north‐eastern region of Croatia could help in introducing RHD molecular screening of blood donors in a routine workflow.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom